Abstract:Background Vessel graft failure is typically associated neointimal formation and arteriosclerosis, in which endothelial dysfunction/damage is a key event.1 Resveratrol has been shown to possess cardioprotective capacity and to reduce atherosclerosis, through its anti-oxidant and anti-apoptotic properties.2–4 However, it is unknown whether it influences the behavior of resident stem cells in the vessel wall leading to the development of arteriosclerosis. Methods and results In the present study, the mouse model of vein grafts was established by grafting vena cava to carotid artery using a cuff technique. ApoE knockout animals were randomly assigned to two groups, one receiving a diet enriched with resveratrol and one control group on a normal diet. It was found that neointimal lesions 4 weeks postoperatively were significantly reduced in resveratrol-treated group compared to untreated controls. Immunostaining for cell components in the grafts revealed the presence of Sca-1+ progenitor cells in the lesional adventitia and neointima of vein grafts. Subsequently, Sca-1+ cells from 4-week vein grafts were cultivated and isolated. Interestingly, stem/progenitor cell differentiation into endothelial lineage was markedly increased by treatment with resveratrol in vitro. We investigated the mechanism involved in the resveratrol-induced progenitor cell differentiation and identified miR-21 as a target of resveratrol. We demonstrated that resveratrol significantly reduced miR-21 expression during endothelial differentiation of progenitor cells, which in turn reduced Akt phosphorylation. This signal cascade diminished the amount of nuclear β-catenin, ultimately inducing endothelial marker expression and tube-like formation capacity in stem/progenitor cells. Both the inhibition of miR-21 and the knockdown of β-catenin were able to resemble the effect of resveratrol application, i.e. reducing endothelial differentiation. Finally, the effect of resveratrol on progenitor cell differentiation was blunted by the overexpression of miR-21. Conclusion We provide the first evidence that oral administration of resveratrol can reduce neointimal formation in an animal model of vein graft, by inducing re-endothelialization through progenitor cell differentiation. We established that the mechanism involved is miR-21/Akt/β-catenin dependent. These findings might contribute to explain the beneficial effect of red wine consumption on vascular disease.

Resveratrol modulates angiogenesis through the GSK3β/β-catenin/TCF-dependent pathway in human endothelial cells.

Resveratrol Prevents Endothelial Progenitor Cells from Senescence and Reduces the Oxidative Reaction Via PPAR-γ/HO-1 Pathways

[Resveratrol Protects Against Hydrogen Peroxide Induced Injury in Human Umbilical Vein Endothelial Cells].

Regulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extracts.

161 RESVERATROL REDUCES VESSEL-GRAFT NEOINTIMAL FORMATION BY INDUCING ENDOTHELIAL DIFFERENTIATION OF RESIDENT PROGENITOR CELLS THROUGH A MIR-21/AKT/B-CATENIN PATHWAY

Resveratrol Inhibits VEGF Expression of Human Hepatocellular Carcinoma Cells Through a NF-kappa B-mediated Mechanism.

FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol

Resveratrol Reduces Vessel-Graft Neointimal Formation By Inducing Endothelial Differentiation Of Resident Progenitor Cells Through A Mir-21/Akt/B-Catenin Pathway

Resveratrol-Induced Vascular Progenitor Differentiation towards Endothelial Lineage via MiR-21/Akt/β-Catenin Is Protective in Vessel Graft Models.

Resveratrol-Induced Vascular Progenitor Differentiation Towards Endothelial Lineage Via MiR-21/Akt/β-Catenin is Protective in Vessel Graft Models

Resveratrol Reduces Endothelial Progenitor Cells Senescence Through Augmentation of Telomerase Activity by Akt‐dependent Mechanisms

Resveratrol modulates signalling to inhibit vascular smooth muscle cell proliferation induced by angiotensin II and high glucose

Absorption of Resveratrol by Vascular Endothelial Cells Through Passive Diffusion and an SGLT1-mediated Pathway

Proteomics analysis of human umbilical vein endothelial cells treated with resveratrol

Effect of Resveratrol on Proliferation and Differentiation of Endothelial Progenitor Cells from Peripheral Blood in Vitro

Resveratrol derivative, trans-3,5,4'-trimethoxystilbene, exerts antiangiogenic and vascular-disrupting effects in zebrafish through the downregulation of VEGFR2 and cell-cycle modulation.

Resveratrol regulates mitochondrial reactive oxygen species homeostasis through Sirt3 signaling pathway in human vascular endothelial cells

Resveratrol Promotes Angiogenesis in a FoxO1-Dependent Manner in Hind Limb Ischemia in Mice

Resveratrol Protects HUVECs from Oxidized-LDL Induced Oxidative Damage by Autophagy Upregulation via the AMPK/SIRT1 Pathway

Resveratrol protects against atherosclerosis by downregulating the PI3K/AKT/mTOR signaling pathway in atherosclerosis model mice

Resveratrol Attenuates High Glucose-Induced Vascular Endothelial Cell Injury by Activating the E2F3 Pathway